Table 5.
Cost-Utility Results.
| Costs (2016 pound sterling) | QALYs | Combined hypoglycemic eventsa | Incremental cost-effectiveness ratio (pound sterling per QALY) | |
|---|---|---|---|---|
| Scenario 1 (lifetime time horizon). % error associated with HbA1c but NOT directly associated with hypoglycemic events | ||||
| Type 1 diabetes | ||||
| SMBG device with 15% error, £0.20 per strip | £81 809 | 15.292 | — | — |
| SMBG device with 8.4% error, £0.30 per strip | £82 182 | 15.414 | — | £3064/QALY |
| Type 2 Diabetes | ||||
| SMBG device with 15% error, £0.20 per strip | £39 523 | 9.743 | — | — |
| SMBG device with 8.4% error, £0.30 per strip | £41 176 | 9.750 | — | £264 668/QALY |
| Scenario 2 (3-year time horizon). % error associated with hypoglycemic events but NOT directly associated with changes in HbA1c | ||||
| Type 1 diabetes | ||||
| SMBG device with 15% error, £0.20 per strip | £7296 | 2.142 | 4.85 | — |
| SMBG device with 8.4% error, £0.30 per strip | £7191 | 2.155 | 3.74 | Dominantb |
| Type 2 diabetes | ||||
| SMBG device with 15% error, £0.20 per strip | £5223 | 2.166 | 4.25 | — |
| SMBG device with 8.4% error, £0.30 per strip | £5174 | 2.178 | 3.28 | Dominantb |
a
All severe hypoglycemic events requiring inpatient visits and hypoglycemic events requiring outpatient visits.
b
Less costly and more effective.